Approximately 1:30 EST – Tuesday, May 22, 2007
New Green Baron Focus Stock Pick;
Now Upgraded to Fully Profiled Pick
HealthSonix, Inc.
(PK: HSXI - .35 per share)
Insight. Innovation. Integrity
www.HealthSonix.com
Common Shares Outstanding / 51.9 million
Current Market Cap / $18.16 million
52-Week High / $1.34 per share
52-Week Low / .075 per share
Average Price / .2030 (50-day) .4142 (200-day)
Average Volume / 512,600 (50-day) 364,000 (200-day)
HealthSonix Ready to Widely Distribute FDA Registered Drug Free Pain Relief Products for Arthritis and other Musculoskeletal Conditions
Infomercials, MyArthritisStore.com, and Co-Marketing Agreements Expected to Create Huge Sales Growth
The Green Baron Report has been closely watching developments at HealthSonix ever since we first interviewed the company back in February. The potential for this Company is simply jaw dropping, and quite honesty, we had trouble at first believing that this company really had such effective products. Simply put, the market for its pain relieving products is many billions of dollars each year, and even a small percentage of this market would be huge. Under much further investigation, we not only believe the claims from the Company, but we think this is just the start of a much bigger move up in the stock due to greatly improving fundamental and technical reasons.
The Green Baron Report is proud to announce that HealthSonix, Inc. (PK: HSXI) is officially our 62nd fully profiled stock and will be added to our storied list of previously profiled stocks on our home page. Results compiled from the most recent trade possible prior to dissemination of this report to the subsequent high will be monitored at www.thegreenbaron.com. Although we have very aggressive short and long term expectations for this stock, we still suggest our members try to accumulate at or as near the profile price as possible.
NOTE: HealthSonix, Inc. was originally introduced by The Green Baron Report through a webcast interview with its CEO in February, 2007. Although HSXI has performed strongly over the past month or so, we believe that recent consolidation is over in the mid .30 per share range, and the stock is now ready for its next move higher. Over the past five weeks, we successfully alerted our members within days of the two huge percentage moves up in HSXI stock. We have reason to believe once again, a third time, that HSXI will rally over the near term to much higher levels, and a move well above $1.00 per share could occur over the next 90 days.
It has become increasingly important to manage pain associated with arthritis and other musculoskeletal conditions without the use of drugs. Due to adverse side affects, addiction concerns, and other negative reactions to prescription pain killers, there is a growing need for “non-pharmacologic” treatments, or at least a combination of non-pharmacologic and pharmacologic modalities of treatment.
HealthSonix offers a variety of proven non-pharmacologic therapies with its proprietary sound pressure wave treatments, such as AquaSonix Therapy – a therapeutic water program that combines the Company’s sound pulse technology with the Arthritis Foundation’s low impact exercises in warm water therapy pools. The proprietary sound pulse technology is believed to work by stimulating mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control of pain); by creating an exercise effect in the muscles, which encourages the production and release of endorphins, the body’s natural pain killers.
Over the past two months, HealthSonix has released several announcements that identify the Company’s coming high growth phase, and its establishment as a new force in massive markets. More specifically, we are impressed by a press release issued on Wednesday, April 11, 2007 where HealthSonix announced it will conduct joint clinical studies with major drug manufacturers. We believe the big pharmaceutical companies are beginning to take notice, and it is only a matter of time before stronger collaborations are forged.
Among other releases, HealthSonix has recently launched a new pain relieving cream under the ZingiberRx brand name priced at about $20, is set to launch MyArthritisStore.com, and has announced positive reviews and studies for its products. See Recent Key Press Releases below for more information. Fundamentally, The Green Baron Report believes HealthSonix is at the best point in the Company’s history, and we expect the Company to surprise us with more fantastic new developments in the near future.
HSXI appears to be under accumulation by some very smart buyers. The stock has held steady at about .34 to .36 per share for about two weeks now. HSXI has hit .50 per share and .45 per share on its last two moves up on heavy volume. The next break over .45 per share should take the stock on another big move up. The recent 10 day average volume is over 700,000 shares traded. Liquidity is fantastic and the spread is typically a penny or less.
We note that HSXI traded between about .60 per share and $1.20 per share from June to September of 2006. Year-end tax selling and a few impatient shareholders took HSXI down late last year. We believe HealthSonix is aiming to gain a listing on the American Stock Exchange this year, and discussions with those close to HealthSonix believe the stock will be above $1 per share within weeks.
http://www.thegreenbaron.com/Stock%20Picks/05-22-07%20Stock%20Pick.htm
|
Thread abonnieren
